I. Buchheit

Institut de Cancérologie de Lorraine

Papers

1

Total Citations

13

H-Index

1

About

I. Buchheit is a leading researcher in the field of radiation oncology, with a primary focus on stereotactic radiosurgery (SRS) for brain metastases. Their most-cited work, a 2023 comparative study, rigorously evaluates the HyperArc™ technique against the CyberKnife® technique, two advanced modalities for treating brain metastases. This research provides critical insights into treatment planning efficiency, dose distribution, and clinical outcomes, helping to guide clinical decision-making for optimal patient care. With 13 citations, this study has already garnered significant attention, reflecting its practical importance in improving stereotactic treatment protocols. Buchheit’s contributions are notable for bridging technical innovation with clinical application, offering evidence-based comparisons that enhance precision and reduce treatment times. Their work is particularly valuable for radiation oncologists and medical physicists seeking to refine SRS techniques, and it underscores their role in advancing the field of neuro-oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Comparison between the HyperArc™ technique and the CyberKnife® technique for stereotactic treatment of brain metastases
13 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Institut de Cancérologie de Lorraine

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago